Weekly Newsletter   Challenge account   Weekly Newsletter   

Dividend stocks? How about Johnson & Johnson?

During this volatile market we can see a lot of stocks being driven by the market up and down. Many with no particular reason or based on short term look. Recently I was reviewing Johnson & Johnson (JNJ) because it was running up and down and today it again loses ground quite a lot. As a dividend investor I am trying to ignore these days and stick with the stock, hold it and if I can get some money buy more. But I need an assurance that I am holding the right stock. So I checked the overall picture of this stock and its chart with splits and I could see steady growth in value. Combined with roughly 45 years of growing dividend I do not see an issue to hold this stock.

This article originally appeared on The DIV-Net May 17, 2010.

Linked here is a detailed quantitative analysis of Johnson & Johnson (JNJ). Below are some highlights from the above linked analysis:

Company Description: Johnson & Johnson engages in the manufacture and sale of various products in the health care field worldwide.


Conclusion: JNJ earned one Star in the Fair Value section, earned three Stars in the Dividend Analytical Data section and earned one Star in the Dividend Income vs. MMA section for a total of five Stars. This quantitatively ranks JNJ as a 5 Star-Strong Buy (as of May 17, 2010).
Read the rest of this entry ยป

Leave a Reply

Your email address will not be published. Required fields are marked *